232 related articles for article (PubMed ID: 10767348)
1. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M
Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348
[TBL] [Abstract][Full Text] [Related]
2. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
[TBL] [Abstract][Full Text] [Related]
3. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
Lux A; Attisano L; Marchuk DA
J Biol Chem; 1999 Apr; 274(15):9984-92. PubMed ID: 10187774
[TBL] [Abstract][Full Text] [Related]
4. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.
Azuma H
J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486
[TBL] [Abstract][Full Text] [Related]
5. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.
Pece N; Vera S; Cymerman U; White RI; Wrana JL; Letarte M
J Clin Invest; 1997 Nov; 100(10):2568-79. PubMed ID: 9366572
[TBL] [Abstract][Full Text] [Related]
6. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin.
Cymerman U; Vera S; Pece-Barbara N; Bourdeau A; White RI; Dunn J; Letarte M
Pediatr Res; 2000 Jan; 47(1):24-35. PubMed ID: 10625079
[TBL] [Abstract][Full Text] [Related]
7. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.
Wallace GM; Shovlin CL
Thorax; 2000 Aug; 55(8):685-90. PubMed ID: 10899246
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
[TBL] [Abstract][Full Text] [Related]
10. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
[TBL] [Abstract][Full Text] [Related]
11. Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia.
Bourdeau A; Faughnan ME; Letarte M
Trends Cardiovasc Med; 2000 Oct; 10(7):279-85. PubMed ID: 11343967
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood.
Harrison RE; Berger R; Haworth SG; Tulloh R; Mache CJ; Morrell NW; Aldred MA; Trembath RC
Circulation; 2005 Feb; 111(4):435-41. PubMed ID: 15687131
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
[TBL] [Abstract][Full Text] [Related]
14. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.
Letteboer TG; Zewald RA; Kamping EJ; de Haas G; Mager JJ; Snijder RJ; Lindhout D; Hennekam FA; Westermann CJ; Ploos van Amstel JK
Hum Genet; 2005 Jan; 116(1-2):8-16. PubMed ID: 15517393
[TBL] [Abstract][Full Text] [Related]
15. Genetic abnormalities in hereditary hemorrhagic telangiectasia.
Marchuk DA
Curr Opin Hematol; 1998 Sep; 5(5):332-8. PubMed ID: 9776212
[TBL] [Abstract][Full Text] [Related]
16. Altered endothelial gene expression associated with hereditary haemorrhagic telangiectasia.
Thomas B; Eyries M; Montagne K; Martin S; Agrapart M; Simerman-François R; Letarte M; Soubrier F
Eur J Clin Invest; 2007 Jul; 37(7):580-8. PubMed ID: 17576210
[TBL] [Abstract][Full Text] [Related]
17. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.
Bourdeau A; Cymerman U; Paquet ME; Meschino W; McKinnon WC; Guttmacher AE; Becker L; Letarte M
Am J Pathol; 2000 Mar; 156(3):911-23. PubMed ID: 10702408
[TBL] [Abstract][Full Text] [Related]
18. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.
Ota T; Fujii M; Sugizaki T; Ishii M; Miyazawa K; Aburatani H; Miyazono K
J Cell Physiol; 2002 Dec; 193(3):299-318. PubMed ID: 12384983
[TBL] [Abstract][Full Text] [Related]
19. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function.
Paquet ME; Pece-Barbara N; Vera S; Cymerman U; Karabegovic A; Shovlin C; Letarte M
Hum Mol Genet; 2001 Jun; 10(13):1347-57. PubMed ID: 11440987
[TBL] [Abstract][Full Text] [Related]
20. Molecular defects in rare bleeding disorders: hereditary haemorrhagic telangiectasia.
Shovlin CL
Thromb Haemost; 1997 Jul; 78(1):145-50. PubMed ID: 9198145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
